ID: ALA1473899

Max Phase: Preclinical

Molecular Formula: C8H8N2O2S

Molecular Weight: 196.23

Molecule Type: Small molecule

Representations

Canonical SMILES:  CS(=O)(=O)/C(C#N)=C/c1ccc[nH]1

Standard InChI:  InChI=1S/C8H8N2O2S/c1-13(11,12)8(6-9)5-7-3-2-4-10-7/h2-5,10H,1H3/b8-5+

Standard InChI Key:  WPZGDMHEBVYNLZ-VMPITWQZSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 196.23

Molecular Weight (Monoisotopic): 196.0306

AlogP: 0.92

#Rotatable Bonds: 2

Polar Surface Area: 73.72

Molecular Species: NEUTRAL

HBA: 3

HBD: 1

#RO5 Violations: 0

HBA (Lipinski): 4

HBD (Lipinski): 1

#RO5 Violations (Lipinski): 0

CX Acidic pKa:

CX Basic pKa:

CX LogP: -0.01

CX LogD: -0.01

Aromatic Rings: 1

Heavy Atoms: 13

QED Weighted: 0.71

Np Likeness Score: -1.06

References

1. PubChem BioAssay data set, 

2. Bachovchin DA, Zuhl AM, Speers AE, Wolfe MR, Weerapana E, Brown SJ, Rosen H, Cravatt BF..  (2011)  Discovery and optimization of sulfonyl acrylonitriles as selective, covalent inhibitors of protein phosphatase methylesterase-1.,  54  (14): [PMID:21639134] [10.1021/jm200502u]

Source

Source(2):

• Scientific Literature
• PubChem BioAssays